Trial Profile
Phase IV trials of an injectable formulation of sustained-release leuprorelin for prostate cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2014
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 11 Feb 2014 New trial record